Quarterly review of quarterly financial statements
First written in FY2020-Q1. 12 of 14 entries say "Restated". Latest entry: FY2025-H1.
Daishin Chemical moved to the "Worse" side of this theme in 2024.
The whole theme swung hardest in 2024: 1 of 8 companies on the "Worse" side.
0 other companies' latest entry also says "Reframed".
- FY2025-H1ReframedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone an interim review by 應和監査法人 of its interim consolidated financial statements for the interim consolidated accounting period (1 April 2024 to 30 September 2024).」
The disclosure has changed from a quarterly review of quarterly financial statements to an interim review of interim consolidated financial statements. - FY2024-Q2RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its consolidated quarterly financial statements for the second-quarter consolidated accounting period (1 July 2023 to 30 September 2023) and the second-quarter consolidated cumulative period (1 April 2023 to 30 September 2023).」
The consolidated quarterly financial statements for the second quarter after the company became consolidated also underwent a quarterly review by 應和監査法人. - FY2024-Q1RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its consolidated quarterly financial statements for the first-quarter consolidated accounting period (1 April 2023 to 30 June 2023) and the first-quarter consolidated cumulative period (1 April 2023 to 30 June 2023).」
The consolidated quarterly financial statements for the first quarter after the company became consolidated also underwent a quarterly review by 應和監査法人. - FY2023RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its consolidated quarterly financial statements for the third-quarter consolidated accounting period (1 October 2022 to 31 December 2022) and the third-quarter consolidated cumulative period (1 April 2022 to 31 December 2022).」
Even after the company became consolidated, it has continued its audit arrangements under which its quarterly financial statements undergo a quarterly review by 應和監査法人. - FY2023-Q3RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its consolidated quarterly financial statements for the third-quarter consolidated accounting period (1 October 2022 to 31 December 2022) and the third-quarter consolidated cumulative period (1 April 2022 to 31 December 2022).」
The company has reaffirmed that its consolidated financial statements for the third quarter underwent a quarterly review by 應和監査法人. - FY2023-Q2RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the second-quarter accounting period (1 July 2022 to 30 September 2022) and the second-quarter cumulative period (1 April 2022 to 30 September 2022).」
The company has reaffirmed that its quarterly financial statements for the second-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2023-Q1RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the first-quarter accounting period (1 April 2022 to 30 June 2022) and the first-quarter cumulative period (1 April 2022 to 30 June 2022).」
The company has reaffirmed that its quarterly financial statements for the first-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2022-Q2RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the second-quarter accounting period (1 July 2021 to 30 September 2021) and the second-quarter cumulative period (1 April 2021 to 30 September 2021).」
The company has reaffirmed that its quarterly financial statements for the second-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2021-Q3RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the third-quarter accounting period (1 October 2020 to 31 December 2020) and the third-quarter cumulative period (1 April 2020 to 31 December 2020).」
The company has reaffirmed that its quarterly financial statements for the third-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2021-Q2RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the second-quarter accounting period (1 July 2020 to 30 September 2020) and the second-quarter cumulative period (1 April 2020 to 30 September 2020).」
The company has reaffirmed that its quarterly financial statements for the second-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2021-Q1RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the first-quarter accounting period (1 April 2020 to 30 June 2020) and the first-quarter cumulative period (1 April 2020 to 30 June 2020).」
The company has reaffirmed that its quarterly financial statements for the first-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2020-Q3RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the third-quarter accounting period (1 October 2019 to 31 December 2019) and the third-quarter cumulative period (1 April 2019 to 31 December 2019).」
The company disclosed that its quarterly financial statements for the third-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2020-Q2RestatedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the second-quarter accounting period (1 July 2019 to 30 September 2019) and the second-quarter cumulative period (1 April 2019 to 30 September 2019).」
The company disclosed that its quarterly financial statements for the second-quarter accounting period and cumulative period underwent a review by 應和監査法人. - FY2020-Q1First statedAnnual report
「Pursuant to Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act, the company has undergone a quarterly review by 應和監査法人 of its quarterly financial statements for the first-quarter accounting period (1 April 2019 to 30 June 2019) and the first-quarter cumulative period (1 April 2019 to 30 June 2019).」
The company disclosed that its quarterly financial statements for the first-quarter accounting period and first-quarter cumulative period underwent a quarterly review by 應和監査法人.